SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $808,000 | +40.3% | 53,912 | +13.9% | 0.00% | +100.0% |
| Q1 2016 | $576,000 | -11.7% | 47,315 | +15.5% | 0.00% | -50.0% |
| Q4 2015 | $652,000 | +5.5% | 40,967 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $618,000 | -37.1% | 40,321 | -0.2% | 0.00% | 0.0% |
| Q2 2015 | $983,000 | +5.9% | 40,421 | +1.2% | 0.00% | 0.0% |
| Q1 2015 | $928,000 | -8.8% | 39,928 | -1.5% | 0.00% | 0.0% |
| Q4 2014 | $1,018,000 | -18.9% | 40,528 | +0.4% | 0.00% | -33.3% |
| Q3 2014 | $1,255,000 | +21.6% | 40,355 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $1,032,000 | +29.0% | 39,926 | +16.7% | 0.00% | +50.0% |
| Q1 2014 | $800,000 | -7.4% | 34,226 | +0.6% | 0.00% | 0.0% |
| Q4 2013 | $864,000 | +27.8% | 34,026 | +2.7% | 0.00% | 0.0% |
| Q3 2013 | $676,000 | +10.8% | 33,126 | +13.9% | 0.00% | 0.0% |
| Q2 2013 | $610,000 | +114.0% | 29,077 | +79.0% | 0.00% | +100.0% |
| Q1 2013 | $285,000 | – | 16,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |